Understanding Mesothelioma Diagnosis: Looking Beyond Tests

Understanding Mesothelioma Diagnosis: Looking Beyond Tests

Mesothelioma is a challenging cancer to diagnose. A recent study highlighted a problem called overdiagnosis. This happens when tumors are mistaken for mesothelioma. It can lead to big challenges in treatment. The study suggests that doctors need to think beyond just using lab tests for diagnosis.

Uncovering Overdiagnosis

The study looked at 311 tumors that were first thought to be mesothelioma but turned out not to be. While these misdiagnoses were rare (only 0.8% of cases), they caused significant problems. Some tumors were actually cancers from other parts of the body. While others were non-cancerous conditions that looked like mesothelioma.

Mistakes in diagnosis were often due to not looking at all the available information. Doctors can rely too much on certain tests and ignore other helpful tests. The study suggests that doctors should consider all patient information. And they should use different tests to make a correct diagnosis.

Improving Diagnosis Practices

While there are guidelines for diagnosing mesothelioma, few studies have looked at why mistakes happen. This study suggests that doctors and labs should review their practices. They should understand how different tests can help. And they should focus on making accurate diagnoses without unnecessary costs.

The College of American Pathologists supports programs to improve lab practices. But these programs are not widely used. The study suggests that more labs should use these programs to reduce diagnostic errors.

Researchers also recommend that doctors get second opinions. This will help review each other’s work. And quality programs can also help to catch mistakes early. With diagnostic errors happening in 3% to 9% of cases, a systematic approach to diagnosis is crucial.

The study also suggests that new pathologists should be trained to think carefully about each case and not rely too heavily on tests. They should learn to use tests based on the patient’s specific situation.

Future Directions: Better Diagnostic Approaches

The study suggests that future research should focus on creating better ways to diagnose mesothelioma. By combining patient information, imaging, and pathology, doctors can improve accuracy and reduce errors.

The study highlights the importance of looking beyond standard tests for mesothelioma diagnosis. By learning from mistakes, reassessing practices, and training pathologists differently, doctors can improve how they diagnose mesothelioma, leading to better outcomes for patients.

Source:

Marchevsky, Alberto M. “Overdiagnosis of Diffuse Mesothelioma: A Reminder That Pathologists Need to Think Outside the ‘Immunohistochemistry Diagnostic Box.’” Annals of Diagnostic Pathology 68 (February 1, 2024): 152264. https://doi.org/10.1016/j.anndiagpath.2024.152264.

Similar Posts

  • |

    Mesothelioma Blood Test May Be Possible

    An international team of researchers is studying the proteins found on the surface of cancer cells in an effort to improve mesothelioma diagnosis. The team, made up of scientists from the US, Switzerland, Italy and Chile, has just published their findings on a new kind of test to identify protein-derived mesothelioma biomarkers in blood serum. Mesothelioma is an aggressive cancer of the membranes around organs. Because the most common mesothelioma biomarker, mesothelin, is also overproduced by other kinds of cancer cells, it has only limited diagnostic value. A test to identify a set of proteins produced specifically by mesothelioma cells could greatly improve diagnostic accuracy. Led by Ferdinando Cerciello and Bernd Wollscheid of the Institute of Molecular Systems Biology in…

  • | |

    Needle Biopsy “Simple, Safe & Accurate” for Mesothelioma

    Mesothelioma researchers in China say a biopsy method that involves a single skin puncture can produce good diagnostic results for mesothelioma patients with little pain or risk. The study focused on percutaneous (through the skin) biopsy in patients who had unexplained fluid buildup or swelling in their abdomens. Abdominal distension and fluid buildup (called ascites) can be signs of peritoneal mesothelioma, a rare but aggressive cancer of the abdominal lining caused by exposure to asbestos. Peritoneal mesothelioma accounts for less than 30% of all mesothelioma cases. Because the symptoms may be vague and often develop many decades after asbestos exposure, peritoneal mesothelioma can be especially challenging to diagnose.  Misdiagnosis and under-diagnosis are not uncommon. In the newest study on percutaneous…

  • | |

    Inflammation Both “Friend and Foe” in Mesothelioma

    An immune system response that causes mesothelioma symptoms such as fever, fatigue, and weight loss may also be helpful to clinicians as a way to find and treat the disease. Scientists with The Asbestos Diseases Research Institute in Sydney, Australia make that case that both systemic inflammation (throughout the body) and at the site of a tumor – has long been associated with mesothelioma and other cancers. Inflammation results when the body attempts to address the imbalances of cancer by producing more of certain immune system cells. Some inflammatory markers, such as CD+8 T-cells and C-reactive protein, have been linked to better prognosis in mesothelioma. Other inflammatory markers, such as certain macrophages and a high neutrophil-to-lymphocyte ratio, can signal the…

  • | |

    FDG PET-CT Results Could Lead to Improved Mesothelioma Treatment

    In a recent study, researchers say a better understanding of certain diagnostic criteria could result in more targeted treatments for malignant mesothelioma. In a recent published report, doctors from the medical school at Dicle University in Diyarbakir, Turkey measured the relationship between PET-CT scan results and survival in 177 patients with malignant pleural mesothelioma. The patients were diagnosed between April 2007 and April 2011. They had a mean age of 55.4 and most (56%) were male. Patients in the study all had FDG PET-CT scans before beginning their mesothelioma treatment. FDG PET-CT scanning is a powerful imaging tool for mesothelioma and other cancers that combines a radioactive tracer with a combination of positron emission tomography and computed tomography scanning.  Because…

  • | |

    Mesothelioma Surgeons Report New Biopsy Technique

    A team of surgeons in Maryland have demonstrated how using a standard biopsy tool in a new way could improve the biopsy process for certain mesothelioma patients. An aggressive cancer of the pleural lining around the lungs, malignant pleural mesothelioma usually requires a tissue biopsy to make a definitive diagnosis. Often this is done using a rigid tool called a thoracoscope inserted into the chest wall while the patient is under general anesthesia. However, mesothelioma doctors at Walter Reed National Military Medical Center detail the case of a 79-year-old suspected mesothelioma patient whose biopsy was done in a minimally-invasive way, under conscious sedation, thanks to the novel use of a standard tool. Although the patient had several of the common signs…

  • |

    New Serum Marker Could Improve Mesothelioma Diagnosis

    Japanese researchers believe they have found a way to diagnose a rare form of mesothelioma earlier using a simple blood test. Diffuse malignant peritoneal mesothelioma (DMPM), which represents about a fourth of all mesothelioma cases, is an aggressive malignancy that spreads across the lining of the abdomen. In most cases, DMPM is lethal within a year. The standard treatment for diffuse malignant peritoneal mesothelioma is cytoreductive surgery to remove as much of the mesothelioma as possible, followed by intraperitoneal chemotherapy to destroy residual cancer cells. In some studies, this approach has resulted in 5-year survival rates of 30 to 60 percent. However, it is most successful when it is performed early, while the primary mesothelioma tumor is more easily removed. Like all forms of…